Perioperatives Management von Patienten unter ... - Vascularcare.de

Originalie
[10] Broad L, Lee T, Conroy M, Bolsin S, Orford N, Black A, Birdsey G:
Successful management of patients with a drug-eluting coronary
stent presenting for elective, non-cardiac surgery. Br J Anaesth. Jan
98 (1) (2007) 19–22. Epub (2006) Nov 22
[11] Carlsson J, von Wagenheim B, Linder R, Anwari TM, Qvist J,
Petersson I, Magounakis T, Lagerqvist B: Is late stent thrombosis in
drug-eluting stents a real clinical issue A single-center experience
and review of the literature. Clin Res Cardiol. Feb 96 (2) (2007)
86–93
[12] Cutlip DE, Baim DS, Ho KK: Stent thrombosis in the modern era: a
pooled analysis of multicenter coronary stent clinical trials. Circulation
103 (2001) 1967–71
[13] Eagle KA, Berger PB, Calkins H et al.: ACC/AHA guideline update
for perioperative cardiovascular evaluation for noncardiac surgery –
executive summary. J Am Coll Cardiol 39 (2002) 542–53
[14] Ernst H: Severity of Bleeding in 48 Patients After Transbronchial
Biopsy by Antiplatelet Use. Chest 129 (2006) 734
[15] Food and Drug Administration: Circulation system devices advisory
panel transcript for December 8 (2006), meeting. Accessed
January 25 (2007) http://www.fda.gov/ohrms /dockets/ac/06/
transcripts/2006-4253t2.rtf
[16] Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW,
Ray JG: Prevention of venous thromboembolism: the Seventh ACCP
Conference on Antithrombotic and Thrombolytic Therapy. Chest.
126 (3 Suppl) (2004) 338S–400S
[17] Gogarten W, VanAken H, Büttner J: Rückenmarksnahe Regionalanästhesien
und Thromboembolieprophylaxe/antithrombotische
Medikation. Anästh Intensivmed 44 (2003) 218–30
[18] Horlocker TT, Wedel DJ, Benzon H: Regional anesthesia in
anticoagulated patients: defining the risks (the second ASRA
Conference of Neuroaxial Anesthesia and Anticoagulation). Reg
Anesth Pain Med 28 (2003) 172–98
[19] Kaluza GL, Joseph J, Lee JR et al.: Catastrophic outcomes of
noncardiac surgery soon after coronary stenting. J Am Coll Cardiol
35 (2000) 1288–95
[20] Kapetanakis EI, Medlam DA, Boyce SW, Haile E, Hill PC, Dullum
MK, Bafi AS, Petro KR, Corso PJ: Clopidogrel administration prior to
coronary artery bypass grafting surgery: the cardiologist’s panacea
or the surgeon’s headache Eur Heart J. 26 (2005) 576–83
[21] Kapetanakis EI, Medlam DA, Petro KR, Haile E, Hill PC, Dullum
MKC, Bafi AS, Boyce SW, Corso PJ: Effect of clopidogrel premedication
in off-pump cardiac surgery: are we forfeiting the benefits
ofreduced hemorrhagic sequelae Circulation.113 (2006) 1667–74
[22] Katritsis DG, Karvouni E, Ioannidis JP: Meta-analysis comparing
drug-eluting stents with bare metal stents. Am J Cardiol 95 (2005)
640–43
[23] Koscielny J, Tempelhoff GF von, Ziemer S: A practical concept
for preoperative management of patients with impaired primary
hemostasis. Clin Appl Thromb Hemost 10 (2004) 155–66
[24] Koscielny J, von Tempelhoff GF, Ziemer S, Radtke H, Schmutzler
M, Sinha P, Salama A, Kiesewetter H, Latza R: A practical concept
for preoperative management of patients with impaired primary
hemostasis. Clin Appl Thromb Hemost 10 (2) (2003) 155
[25] Kozek-Langenecker S, Fries D, Gütl M et al.: Lokoregionalanästhesien
unter gerinnungshemmender Medikation. Empfehlungen
der Arbeitsgruppe Perioperative Gerinnung der Österreichischen
Gesellschaft für Anästhesiologie und Intensivmedizin. Anaesthesist
54 (2005) 476–84
[26] McFadden EP, Stabile E, Regar E et al.: Late thrombosis in drugeluting
coronary stents after discontinuation of antiplatelet therapy.
Lancet 364 (2004) 1519–21
[27] Metzler H, Huber K, Kozek-Langenecker S, Vicenzi MN, Münch
A: Coronary stents, dual antiplatelet therapy and peri-operative
problems. Anaesthesist. Apr 56 (4) (2007) 401–10
[28] Muni MN, Gross TP: Problems with drug-eluting stents – The FDA
perspective. N Engl J Med 351 (2004) 1593–94
42 Vascular Care 1/2008 Vol. 14